Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling.
Ota N, Davies CW, Kang J, Yan D, Scherl A, Wong A, Cook R, Tao X, Dunlap D, Klabunde S, Mantik P, Mohanan V, Lin W, McBride J, Sadekar S, Storek KM, Lupardus P, Ye Z, Ackerly Wallweber H, Kiefer JR, Xu M, Chan P, Nagapudi K, Yi T, Koerber JT.
Ota N, et al.
Proc Natl Acad Sci U S A. 2025 Jun 3;122(22):e2501635122. doi: 10.1073/pnas.2501635122. Epub 2025 May 28.
Proc Natl Acad Sci U S A. 2025.
PMID: 40434646
Free PMC article.